Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 8, Issue 8, pp. 2392-2401
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 4, 2009
- Revision received May 6, 2009
- Accepted May 18, 2009
- Published first August 11, 2009.
Article Versions
- Previous version (August 11, 2009 - 08:30).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2009 American Association for Cancer Research.
Author Information
- Nicole Huebener1,
- Stefan Fest3,
- Kerstin Hilt2,
- Alexander Schramm4,
- Angelika Eggert4,
- Tahir Durmus1,
- Anja Woehler1,
- Alexander Stermann1,
- Matthias Bleeke1,
- Bianca Baykan1,
- Silke Weixler1,
- Gerhard Gaedicke1 and
- Holger N. Lode1
- Departments of 1Pediatrics, Experimental Oncology, Campus Virchow-Klinikum and 2Dermatology and Allergy, Allergy Center Charité, Charité-University Medicine Berlin, Berlin, Germany; 3Pediatric Immunotherapy, University Children's Hospital, Otto-von-Guericke-Universität Magdeburg, Magdeburg, Germany; and 4Department of Pediatric Hematology and Oncology, University of Essen, Essen, Germany
- Requests for reprints:
Holger N. Lode, Department of Pediatrics, Experimental Oncology, Campus Virchow Klinikum, Charité-University Medicine Berlin, Augustenburger Platz 1, Berlin 13353, Germany. Phone: 49-30-450-666233; Fax: 49-30-450-566916. E-mail: holger.lode{at}charite.de
August 2009
Volume 8, Issue 8
Volume 8, Issue 8
Xenogeneic immunization with human tyrosine hydroxylase DNA vaccines suppresses growth of established neuroblastoma
Jump to section
Advertisement